Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: FNF STC TRV RDN ITIC CINF MTG NMIH ESNT HZO

| Held by: IJH VTI VB VBR VXF AVUV MDY FXO DFAT VIG

Index	-	P/E	11.32	EPS (ttm)	6.01	Insider Own	4.41%	Shs Outstand	101.90M	Perf Week	3.58%
Market Cap	6.93B	Forward P/E	10.27	EPS next Y	6.62	Insider Trans	-0.17%	Shs Float	97.41M	Perf Month	12.27%
Enterprise Value	-	PEG	1.34	EPS next Q	1.11	Inst Own	90.64%	Short Float	3.32%	Perf Quarter	6.23%
Income	621.80M	P/S	1.24	EPS this Y	1.93%	Inst Trans	-0.61%	Short Ratio	3.98	Perf Half Y	5.44%
Sales	5.58B	P/B	1.31	EPS next Y	8.24%	ROA	3.99%	Short Interest	3.23M	Perf YTD	10.68%
Book/sh	52.02	P/C	-	EPS next 5Y	7.67%	ROE	9.28%	52W High	68.75 -1.09%	Perf Year	6.82%
Cash/sh	-	P/FCF	9.84	EPS past 3/5Y	34.77% -0.53%	ROIC	8.80%	52W Low	53.09 28.08%	Perf 3Y	13.30%
Dividend Est.	2.22 (3.26%)	EV/EBITDA	-	Sales past 3/5Y	-56.11% -38.13%	Gross Margin	-	Volatility	3.07% 2.92%	Perf 5Y	20.65%
Dividend TTM	2.18 (3.21%)	EV/Sales	-	EPS Y/Y TTM	379.80%	Oper. Margin	-15.94%	ATR (14)	1.97	Perf 10Y	86.81%
Dividend Ex-Date	Mar 09, 2026	Quick Ratio	-	Sales Y/Y TTM	-5.14%	Profit Margin	11.14%	RSI (14)	62.29	Recom	2.00
Dividend Gr. 3/5Y	1.91% 4.14%	Current Ratio	1.19	EPS Q/Q	195.05%	SMA20	4.60%	Beta	1.27	Target Price	79.40
Payout	36.33%	Debt/Eq	0.29	Sales Q/Q	-89.50%	SMA50	7.39%	Rel Volume	1.74	Prev Close	67.22
Employees	19038	LT Debt/Eq	0.29	Earnings	Feb 11 AMC	SMA200	9.48%	Avg Volume	811.17K	Price	68.00
IPO	May 24, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	48.12% 13.77%	Trades		Volume	1,412,899	Change	1.16%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-14-25	Resumed	Stephens	Equal-Weight
Apr-08-25	Upgrade	Keefe Bruyette	Mkt Perform → Outperform	$75
Dec-10-24	Downgrade	Keefe Bruyette	Outperform → Mkt Perform	$80
Mar-21-24	Upgrade	Keefe Bruyette	Mkt Perform → Outperform	$66 → $69
Jan-10-24	Initiated	Deutsche Bank	Buy
Nov-15-23	Initiated	Barclays	Equal Weight	$53
Jul-18-23	Resumed	BTIG Research	Neutral
Feb-10-23	Upgrade	Stephens	Equal-Weight → Overweight	$65 → $72
Dec-15-22	Downgrade	Keefe Bruyette	Outperform → Mkt Perform	$61
Apr-01-22	Downgrade	Credit Suisse	Outperform → Neutral	$97 → $74
Feb-02-22	Initiated	BTIG Research	Buy	$93
May-03-21	Initiated	Credit Suisse	Outperform	$78
Apr-20-20	Downgrade	Stephens	Overweight → Equal-Weight	$76 → $48
Apr-08-20	Upgrade	Keefe Bruyette	Mkt Perform → Outperform	$57
Mar-05-20	Upgrade	Compass Point	Neutral → Buy	$74
Dec-09-19	Downgrade	Keefe Bruyette	Outperform → Mkt Perform
Jun-19-19	Initiated	Susquehanna	Positive
Apr-29-19	Downgrade	Compass Point	Buy → Neutral
Apr-01-19	Upgrade	Piper Jaffray	Neutral → Overweight
Jan-24-19	Initiated	Compass Point	Buy	$58

Show Previous Ratings

Feb-13-26 11:45AM	First American Financial (FAF) Could Be a Great Choice (Zacks)
Feb-12-26 06:00PM	First American Financial Corp (FAF) Q4 2025 Earnings Call Highlights: Strong Commercial Growth ... (GuruFocus.com)
05:19PM	First American Financial Q4 Earnings Call Highlights (MarketBeat)
12:10PM	FAF Q4 Deep Dive: Commercial Strength and New Technology Drive Outperformance (StockStory)
11:24AM	FAF Q4 Earnings Top, Revenues Rise Y/Y on Strong Title Segment (Zacks)
08:30AM	Loading…
08:30AM	First American Financial Corporation Q4 2025 Earnings Call Summary (Moby)
Feb-11-26 08:30PM	First American Financial (FAF) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:55PM	First American Financial (FAF) Beats Q4 Earnings and Revenue Estimates (Zacks)
05:05PM	First American Financial: Q4 Earnings Snapshot (Associated Press Finance)
04:44PM	First American Financial (NYSE:FAF) Delivers Strong Q4 CY2025 Numbers (StockStory)
04:15PM	First American Financial Reports Results for the Fourth Quarter and Full Year of 2025 (Business Wire)
Feb-10-26 05:10PM	United Fire Group (UFCS) Q4 Earnings and Revenues Top Estimates (Zacks)
Feb-09-26 10:03PM	First American Financial (FAF) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Feb-05-26 04:15PM	First American Title Named a 2026 HousingWire Tech100 Real Estate Winner (Business Wire)
Feb-04-26 12:34PM	Is a Beat in Store for Cincinnati Financial This Earnings Season? (Zacks)
10:03AM	Loading…
10:03AM	Will Arch Capital's Beat Streak Continue This Earnings Season? (Zacks)
10:00AM	First American Financial (FAF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Feb-03-26 11:06PM	3 Reasons to Avoid FAF and 1 Stock to Buy Instead (StockStory)
06:00PM	RenaissanceRe (RNR) Beats Q4 Earnings Estimates (Zacks)
Feb-02-26 09:00AM	ServiceMac Surpasses One Million Loans, Exceeds $300 Billion in Subservicing Portfolio (Business Wire)
Jan-29-26 09:40AM	First American Financial (FAF) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Jan-28-26 06:00PM	Axis Capital (AXS) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
Jan-27-26 12:33PM	Can HIG Offset Rising Expenses in Q4 With Higher Premiums? (Zacks)
Jan-24-26 06:47AM	Barclays Updates First American Financial (FAF) in Broader Coverage Reset (Insider Monkey)
Jan-21-26 04:30PM	First American Financial Corporation Declares Quarterly Cash Dividend of 55 Cents Per Share (Business Wire)
09:50AM	Here's Why First American Financial (FAF) is a Strong Momentum Stock (Zacks)
Jan-20-26 09:00AM	National House Prices Nearly Unchanged in 2025, According to First American Data & Analytics Monthly Home Price Index Report (Business Wire)
Jan-15-26 04:15PM	First American Financial Announces Fourth-Quarter and Full-Year 2025 Earnings Conference Call (Business Wire)
Jan-14-26 12:10PM	Why First American Financial (FAF) is Poised to Beat Earnings Estimates Again (Zacks)
Jan-06-26 10:05AM	FAF Stock Trading at a Discount to Industry at 1.19X: Time to Hold? (Zacks)
01:02AM	Loading…
Jan-03-26 01:02AM	First American Financial (FAF) to Benefit From Mortgage Insurance Growth (Insider Monkey)
Jan-01-26 10:35PM	Q3 Earnings Roundup: First American Financial (NYSE:FAF) And The Rest Of The Property & Casualty Insurance Segment (StockStory)
Dec-22-25 09:09AM	Zacks.com featured highlights include Cenovus Energy, CION Investment, Sally Beauty, PG&E and First American Financial (Zacks)
Dec-19-25 09:40AM	Should Value Investors Buy First American Financial (FAF) Stock? (Zacks)
08:21AM	Pick These 5 Bargain Stocks With Impressive EV-to-EBITDA Ratios (Zacks)
Dec-18-25 09:00AM	National House Price Growth Stabilizes in Low Single Digits, According to First American Data & Analytics Monthly Home Price Index Report (Business Wire)
Dec-17-25 09:10AM	Do Options Traders Know Something About First American Stock We Don't? (Zacks)
Dec-09-25 09:00AM	First American Data & Analytics RegsData Compliance Solution Now Integrated with MeridianLink Mortgage LOS (Business Wire)
Dec-03-25 09:40AM	Should Value Investors Buy First American Financial (FAF) Stock? (Zacks)
Dec-02-25 01:01PM	Marsh & McLennan Unit Expands in Hawai'i With Three Brokerage Buys (Zacks)
09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
Nov-28-25 11:30AM	Why Is Axis Capital (AXS) Up 9.2% Since Last Earnings Report? (Zacks)
Nov-21-25 02:41PM	AM Best Affirms Credit Ratings of First American Title Insurance Group Members and First American Financial Corporation (Business Wire)
11:30AM	Why Is First American Financial (FAF) Down 1.3% Since Last Earnings Report? (Zacks)
Nov-20-25 09:01AM	FAF Stock Trading at a Discount to Industry at 1.2X: Time to Buy? (Zacks)
Nov-18-25 09:00AM	House Prices Accelerate for First Time in Nearly a Year, According to First American Data & Analytics Monthly Home Price Index Report (Business Wire)
09:00AM	First American Named to the 2025 Fortune Best Workplaces for Parents List (Business Wire)
Nov-17-25 09:41AM	Are Investors Undervaluing First American Financial (FAF) Right Now? (Zacks)
Nov-14-25 07:44AM	AIZ Raises Quarterly Dividend by 10%, Ups Share Buyback Capacity (Zacks)
Nov-11-25 09:46PM	Truist Lifts Price Target on First American (FAF) Following Solid Q3 Performance (Insider Monkey)
09:00AM	First American Named a 2026 Military Friendly Employer (Business Wire)
Nov-06-25 01:47PM	MetLife Q3 Earnings Beat Estimates on Lower Costs, Asia Unit Strength (Zacks)
09:00AM	First American Mortgage Solutions Launches equiRisk, Expanding its equiSolutions Product Suite for Home Equity Lending (Business Wire)
Nov-04-25 04:55PM	First American Financial Corporation Appoints Jeffrey (Jeff) J. Dailey to Board of Directors (Business Wire)
04:15PM	First American Financial Corporation Declares Quarterly Cash Dividend of 55 Cents Per Share (Business Wire)
09:50AM	Here's Why First American Financial (FAF) is a Strong Momentum Stock (Zacks)
09:35AM	Unum Group Q3 Earnings Miss on Higher Expenses, Revenues Rise Y/Y (Zacks)
09:30AM	CNA Financial Q3 Earnings Beat Estimates on Solid Underwriting (Zacks)
Nov-03-25 01:00PM	First American Title Executive Paul Bandiera Named a 2025 HousingWire Tech Trendsetter (Business Wire)
Oct-29-25 01:06PM	RNR Q3 Earnings Beat on Lower Expenses, Strong Underwriting Results (Zacks)
01:37AM	First American Financial's Q3 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Oct-28-25 09:40AM	Is First American Financial (FAF) Stock Undervalued Right Now? (Zacks)
Oct-24-25 12:40AM	1 Growth Stock with Explosive Upside and 2 We Avoid (StockStory)
Oct-23-25 05:06PM	First American Financial Corp (FAF) Q3 2025 Earnings Call Highlights: Strong Growth in ... (GuruFocus.com)
02:01PM	FAF Q3 Deep Dive: Commercial Title Momentum and AI Investments Offset Residential Weakness (StockStory)
12:15PM	First American Marks a Decade as One of the Fortune Best Workplaces for Women (Business Wire)
10:37AM	FAF Q3 Earnings Top on Solid Investment Income, Dividend Raised (Zacks)
Oct-22-25 07:30PM	Here's What Key Metrics Tell Us About First American Financial (FAF) Q3 Earnings (Zacks)
06:03PM	First American Financial (NYSE:FAF) Delivers Strong Q3 Numbers (StockStory)
05:45PM	First American Financial (FAF) Beats Q3 Earnings and Revenue Estimates (Zacks)
04:47PM	First American Financial: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	First American Financial Reports Third Quarter 2025 Results (Business Wire)
09:25AM	First American Financial Corp (FAF) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-21-25 09:20AM	First American Financial Corp (FAF) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-20-25 11:08PM	First American Financial Earnings: What To Look For From FAF (StockStory)
Oct-16-25 10:00AM	Universal Insurance Holdings (UVE) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
09:00AM	San Diego-Chula Vista-Carlsbad Home Prices Down 2.3% Year Over Year in September, According to First American Data & Analytics Monthly Home Price Index Report (Business Wire)
09:00AM	New York-Jersey City-White Plains Home Prices Up 5.1% Year Over Year in September, According to First American Data & Analytics Monthly Home Price Index Report (Business Wire)
09:00AM	Los Angeles-Long Beach-Glendale Home Prices Down 1.4% Year Over Year in September, According to First American Data & Analytics Monthly Home Price Index Report (Business Wire)
09:00AM	Houston-The Woodlands-Sugar Land Home Prices Down 0.6% Year Over Year in September, According to First American Data & Analytics Monthly Home Price Index Report (Business Wire)
09:00AM	Dallas-Plano-Irving Home Prices Down 1.4% Year Over Year in September, According to First American Data & Analytics Monthly Home Price Index Report (Business Wire)
09:00AM	Cooling National House Prices Mask Regional Differences, According to First American Data & Analytics Monthly Home Price Index Report (Business Wire)
09:00AM	Atlanta-Sandy Springs-Alpharetta Home Prices Up 0.5% Year Over Year in September, According to First American Data & Analytics Monthly Home Price Index Report (Business Wire)
Oct-15-25 10:00AM	First American Financial (FAF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-13-25 04:15PM	First American Financial Announces Third Quarter 2025 Earnings Conference Call (Business Wire)
Oct-10-25 12:02AM	3 Reasons FAF is Risky and 1 Stock to Buy Instead (StockStory)
Oct-08-25 09:40AM	Should Value Investors Buy First American Financial (FAF) Stock? (Zacks)
Oct-05-25 11:12PM	First American Financial (FAF) and the Appeal of Affordable Dividend Stocks for Long-Term Investors (Insider Monkey)
Sep-29-25 11:45AM	Are You Looking for a High-Growth Dividend Stock? (Zacks)
Sep-24-25 01:35PM	MCY Rallies 22.6% YTD, Trades at Premium: Should You Buy the Stock? (Zacks)
01:31PM	TRV Rallies 14.7% YTD, Trades at Premium: Should You Buy the Stock? (Zacks)
Sep-22-25 09:40AM	Are Investors Undervaluing First American Financial (FAF) Right Now? (Zacks)
08:54AM	Heritage Insurance (HRTG) Surges 11.7%: Is This an Indication of Further Gains? (Zacks)
Sep-19-25 12:05PM	FAF Stock Trades at a Discount: Time to Accumulate or Stand By? (Zacks)
Sep-18-25 09:00AM	San Diego-Chula Vista-Carlsbad Home Prices Down 2.7% Year Over Year in August, According to First American Data & Analytics Monthly Home Price Index Report (Business Wire)
09:00AM	National House Price Growth Slows Further in August, Giving Buyers a Chance, According to First American Data & Analytics Monthly Home Price Index Report (Business Wire)
09:00AM	Los Angeles-Long Beach-Glendale Home Prices Down 1.2% Year Over Year in August, According to First American Data & Analytics Monthly Home Price Index Report (Business Wire)
09:00AM	Houston-The Woodlands-Sugar Land Home Prices Down 2.0% Year Over Year in August, According to First American Data & Analytics Monthly Home Price Index Report (Business Wire)
09:00AM	Atlanta-Sandy Springs-Alpharetta Home Prices Up 0.2% Year Over Year in August, According to First American Data & Analytics Monthly Home Price Index Report (Business Wire)
Sep-16-25 12:00PM	What Makes First American Financial (FAF) a New Buy Stock (Zacks)

First American Financial Corp. engages in the provision of title insurance and settlement services to the real estate and mortgage industries. It also provides other financial services and risk solutions. It operates through the following segments: Title Insurance and Services, Specialty Insurance, and Corporate. The Title Insurance and Services segment offers title insurance, escrow, closing services and similar or related financial services domestically and internationally in connection with residential and commercial real estate transactions. The Specialty Insurance segment issues property and casualty insurance policies and sells home warranty products. The Corporate segment includes the investment and management of the company's venture investment portfolio. The company was founded in 1889 and is headquartered in Santa Ana, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DOTI JAMES L	Director	Aug 28 '25	Sale	65.17	7,692	501,298	69,091	Aug 29 06:17 PM
DOTI JAMES L	Director	Aug 28 '25	Proposed Sale	65.17	7,692	501,298		Aug 28 02:30 PM
McCarthy Margaret M	Director	Aug 13 '25	Sale	65.63	3,500	229,705	28,095	Aug 14 05:11 PM
McCarthy Margaret M	Director	Aug 13 '25	Proposed Sale	65.63	3,500	229,705		Aug 13 03:02 PM
DEGIORGIO KENNETH D	Former Officer, Director	Apr 24 '25	Proposed Sale	62.79	250,669	15,739,391		Apr 24 03:34 PM
Seaton Mark Edward	EVP & Chief Financial Officer	Feb 25 '25	Sale	65.27	37,321	2,436,110	158,491	Feb 27 07:07 PM
Cornehl Lisa W	SVP, Chief Legal Officer	Feb 25 '25	Sale	65.49	3,057	200,216	23,825	Feb 27 07:05 PM
Seaton Mark Edward	EVP & Chief Financial Officer	Feb 24 '25	Sale	64.28	12,679	814,947	195,812	Feb 26 08:47 PM
Seaton Mark Edward	Officer	Feb 25 '25	Proposed Sale	65.27	37,321	2,436,111		Feb 25 04:28 PM
Cornehl Lisa W	Officer	Feb 25 '25	Proposed Sale	65.49	3,057	200,216		Feb 25 04:12 PM
Seaton Mark Edward	Officer	Feb 24 '25	Proposed Sale	64.28	12,679	814,947		Feb 24 04:19 PM

Open in Screener

NVO

Novo Nordisk ADR

Feb 17 • 04:00PM ET

49.37

-0.20 -0.40 %

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Peers: LLY MRK ABBV JNJ AMGN AZN-D PFE SNY BMY GSK

| Held by: PVAL PPH AVDE FTHI PID WCMI PINK OZEM AQEC APIE

Index	-	P/E	14.24	EPS (ttm)	3.47	Insider Own	0.00%	Shs Outstand	3.37B	Perf Week	0.00%
Market Cap	166.33B	Forward P/E	14.22	EPS next Y	3.47	Insider Trans	-	Shs Float	3.37B	Perf Month	-13.57%
Enterprise Value	182.69B	PEG	9.00	EPS next Q	0.81	Inst Own	9.03%	Short Float	0.94%	Perf Quarter	0.43%
Income	15.45B	P/S	3.56	EPS this Y	-7.38%	Inst Trans	-2.64%	Short Ratio	1.47	Perf Half Y	-5.80%
Sales	46.77B	P/B	7.19	EPS next Y	3.05%	ROA	20.59%	Short Interest	31.69M	Perf YTD	-2.97%
Book/sh	6.87	P/C	39.23	EPS next 5Y	1.58%	ROE	61.25%	52W High	93.80 -47.37%	Perf Year	-36.60%
Cash/sh	1.26	P/FCF	18.58	EPS past 3/5Y	26.28% 20.36%	ROIC	31.38%	52W Low	43.08 14.60%	Perf 3Y	-30.28%
Dividend Est.	1.69 (3.43%)	EV/EBITDA	8.08	Sales past 3/5Y	23.19% 19.21%	Gross Margin	80.90%	Volatility	2.89% 3.92%	Perf 5Y	30.66%
Dividend TTM	1.73 (3.50%)	EV/Sales	3.91	EPS Y/Y TTM	5.57%	Oper. Margin	41.17%	ATR (14)	2.39	Perf 10Y	94.79%
Dividend Ex-Date	Mar 30, 2026	Quick Ratio	0.57	Sales Y/Y TTM	11.11%	Profit Margin	33.03%	RSI (14)	41.39	Recom	2.21
Dividend Gr. 3/5Y	28.28% 20.66%	Current Ratio	0.80	EPS Q/Q	3.95%	SMA20	-9.66%	Beta	0.70	Target Price	58.24
Payout	38.07%	Debt/Eq	0.67	Sales Q/Q	0.66%	SMA50	-7.44%	Rel Volume	0.46	Prev Close	49.57
Employees	68794	LT Debt/Eq	0.61	Earnings	Feb 04 BMO	SMA200	-15.11%	Avg Volume	21.51M	Price	49.37
IPO	Apr 30, 1981	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.40% 3.10%	Trades		Volume	9,861,117	Change	-0.40%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-12-26	Upgrade	Jefferies	Underperform → Hold
Jan-27-26	Initiated	Citigroup	Neutral
Dec-08-25	Downgrade	Argus	Buy → Hold
Oct-27-25	Resumed	Jefferies	Underperform
Oct-01-25	Upgrade	HSBC Securities	Hold → Buy
Sep-29-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$47
Sep-17-25	Upgrade	Berenberg	Hold → Buy
Sep-16-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy
Sep-09-25	Upgrade	Bernstein	Mkt Perform → Outperform
Aug-13-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$54
Aug-05-25	Downgrade	UBS	Buy → Neutral
Jul-31-25	Downgrade	HSBC Securities	Buy → Hold	$57
Jul-30-25	Downgrade	Barclays	Overweight → Equal Weight
Apr-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$64
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Jan-06-25	Upgrade	Bernstein	Underperform → Mkt Perform
May-30-24	Initiated	Goldman	Buy	$156
Apr-12-24	Initiated	BMO Capital Markets	Outperform	$163

Show Previous Ratings

Today 11:04AM	Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk (Investor's Business Daily)
09:39AM	Novo Nordisks Wegovy Weight Loss Shot Approved at Higher Dose in EU (The Wall Street Journal)
08:59AM	Eli Lilly Stock Rises as $1.5 Billion Weight-Loss Pill Prepares to Hit Market (GuruFocus.com)
08:37AM	Eli Lilly Targets India as Global Export Hub Amid Surging Mounjaro Sales (GuruFocus.com)
Feb-16-26 02:00PM	Why Eli Lillys $1 Billion AI Bet Could Reshape Drug Discovery (24/7 Wall St.)
11:19AM	Loading…
11:19AM	Wall Street Sees 84% Upside in Hims & Hers (HIMS) Despite This Months 48% Selloff (24/7 Wall St.)
10:26AM	NVO Crashes 21% in a Month: Is This an Indication to Sell the Stock? (Zacks)
09:54AM	Prothena Stock Tumbles 36.8% Year Over Year: What Lies Ahead? (Zacks)
Feb-14-26 05:30AM	How Ozempic Brought a Napster Moment to Big Pharma (The Wall Street Journal)
Feb-13-26 02:08PM	Hims & Hers Falls Over 50% as Novo Files Obesity Lawsuit (GuruFocus.com)
12:59PM	Eli Lilly Builds $1.5 Billion Pill Inventory (GuruFocus.com)
12:24PM	Eli Lilly Builds Orforglipron Inventory Ahead of FDA Review (GuruFocus.com)
10:20AM	Novo Nordisk CEO on medicare coverage, new obesity pill, U.S. pricing pressure (CNBC TV)
06:21AM	Analysis-US could take action including fines against Hims after brief Wegovy copy launch (Reuters)
05:36AM	Eli Lilly Builds $1.5 Billion Inventory Of Experimental Weight-Loss Pill As FDA Decision Looms (Benzinga)
01:14PM	Loading…
Feb-12-26 01:14PM	Novo Nordisk plans Wegovy vials amid obesity-drug competition (Proactive)
01:02PM	Novo Nordisk Plans Wegovy Vial Launch To Counter Eli Lilly, Target Broader Obesity Market (Benzinga)
08:42AM	How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report (Zacks)
08:03AM	VKTX Posts Wider-Than-Expected Loss in Q4, Stock Up on Pipeline Updates (Zacks)
08:02AM	McDonald's gears up to battle GLP-1 weight-loss drug pills (Yahoo Finance)
08:02AM	'We know that consumers' behavior changes': McDonald's prepares for wider GLP-1 adoption as weight-loss pills hit market (Yahoo Finance)
07:28AM	Jefferies lifts Novo Nordisk rating as downside risks crystallize (Investing.com)
04:23AM	Novo Nordisk CEO Sees Opportunity For 15 Million New Patients As Medicare Covers Obesity Drugs (Benzinga)
Feb-11-26 09:54AM	Is Novo Nordisk's Turnaround Story at Risk After Weak 2026 Outlook? (Zacks)
08:59AM	Taking the new Wegovy pill every day is really complicated. Will patients stick with it? (MarketWatch)
08:45AM	Novo Nordisk target cut by Deutsche Bank despite long-term optimism (Proactive)
06:46AM	Hims & Hers Halts Compounded Semaglutide Pill Offering After FDA's Crackdown Warning (Benzinga)
Feb-10-26 04:51PM	Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. (Barrons.com)
04:01PM	Gilead's Earnings Surprise. HIV Drug Sales Were Strong. (Barrons.com)
03:48PM	Taking the new Wegovy pill every day is really complicated. Will patients stick with it? (MarketWatch)
03:08PM	Loading…
03:08PM	Why cheaper GLP-1 drugs are facing legal battles (CNBC TV)
10:49AM	Eli Lilly's 2025 Surge Sets the Stage for Another Big Year in 2026 (Zacks)
10:23AM	Novo Nordisk opens new front with patent suit over Hims Wegovy copies (Reuters Videos)
09:59AM	As Hims & Hers Gets Hit With Major Wegovy Loss, Should You Buy the Dip in Deeply Oversold HIMS Stock? (Barchart)
09:00AM	Here is What to Know Beyond Why Novo Nordisk A/S (NVO) is a Trending Stock (Zacks)
08:51AM	Hims & Hers says Novo Nordisk lawsuit blatant attack on millions of Americans (TipRanks)
08:01AM	EXCLUSIVE: Small Biotech Hoth Therapeutics Claims Experimental Obesity Drug Topped Famed Wegovy In Preclinical Study (Benzinga)
07:11AM	Novo Nordisk Rallies 3.6% as Hims & Hers Pulls Compounded Semaglutide (Zacks)
06:41AM	Where is Novo Nordisk A/S (NVO) Headed? (Insider Monkey)
03:02AM	Heard on the Street Monday Recap: Homebuilder Industry Strikes Back (The Wall Street Journal)
12:01AM	Novo Nordisk Launches Suit to Knock Out Hims & Hers Weight Loss Knockoffs (The Daily Upside)
12:01AM	Morgan Stanley Begins Coverage Of Bitcoin Miners As Wider Infrastructure Plays (The Daily Upside)
Feb-09-26 05:20PM	Stocks to Watch Monday Recap: Novo Nordisk, Hims & Hers, Apollo (The Wall Street Journal)
04:19PM	These Stocks Are Todays Movers: Kyndryl, Hims & Hers, Novo Nordisk, Oracle, Nvidia, AppLovin, and More (Barrons.com)
04:15PM	Hims & Hers Plummets On FDA Crackdown, Novo Nordisk Lawsuit (Investor's Business Daily)
04:05PM	FDA Flags Novo Wegovy Pill Ad; Shares Par Gains After 8.95% Rise (GuruFocus.com)
03:44PM	Novo Nordisk, Hims & Hers Health Shares React to Lawsuit (Schaeffer's Research)
03:42PM	Stocks to Watch Monday: Novo Nordisk, Hims & Hers, Apollo (The Wall Street Journal)
02:27PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
02:19PM	Novo Nordisk Escalates Fight Against Hims & Hers (The Wall Street Journal)
02:04PM	Squawk Pod: Super Bowl ads & GLP-1 competition - 02/09/26 Audio Only (CNBC TV)
01:44PM	FDA Uncertainty Pushes Analyst To Lower Hims & Hers Forecast (Benzinga)
01:03PM	Hims & Hers Under Fire, Stock Tanks on Federal Crackdown, Patent War (Benzinga)
12:28PM	Super Bowl Commercials 2026: Complete List Of Ads, The Companies Behind Them And Who Won Over Fans (Benzinga)
11:59AM	HIMs 22% Collapse Looks Like A Buy The Dip Moment (24/7 Wall St.)
11:33AM	Hims & Hers Stock Plunges While Novo Nordisk Gains as Weight-Loss Drug Wars Take New Turn (Investopedia)
11:25AM	Novo sues Hims & Hers despite Wegovy pill offering U-turn (Pharmaceutical Technology)
11:22AM	Dow Jones retreat from highs as Amazon and Apple fall (Proactive)
11:06AM	Stock Market Today: Dow Gains As Nvidia Jumps; Apple Lags, Energy Stock Tests Entry (Live Coverage) (Investor's Business Daily)
11:03AM	Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pills, injections (CNBC TV)
10:49AM	Hims & Hers stock crashes after FDA announces plans to take 'decisive steps' against GLP-1 compounds (Yahoo Finance)
10:24AM	HIMS Stock Tumbles as FDA Scrutiny Boosts Novo Nordisk Shares (GuruFocus.com)
10:18AM	Stock Market Today: Dow Skids Even As Nvidia Jumps; Monday Plunges, Biopharma Funds Lag (Live Coverage) (Investor's Business Daily)
10:12AM	Hims & Hers Halts Knockoff Wegovy Pill After Just Two Days: Here's Why (Investor's Business Daily)
10:10AM	Novo Nordisk has had it up to here with knockoff Ozempic (Quartz)
10:06AM	Novo Nordisk sues Hims & Hers over knockoff weight loss drugs (Quartz)
10:03AM	Dr. Scott Gottlieb on Novo Nordisk vs. Hims & Hers: We have a drug approval process for a reason (CNBC TV)
09:55AM	Novo Nordisk Stock Whipsawed by GLP-1 Pill Fears: Relief Ahead? (Zacks)
09:46AM	Novo Nordisk Takes Legal Action Against Hims & Hers Over Wegovy Knock Offs (Benzinga)
09:44AM	Stock Market Today: Dow Falls As Jobs Report Looms; AI Player Monday Plunges On Earnings (Live Coverage) (Investor's Business Daily)
09:37AM	Novo Nordisk Stock Soars After Hims & Hers Scraps Copycat Weight-Loss Pill (The Wall Street Journal)
09:28AM	Eli Lilly buys Orna, Novo Nordisk sues Hims & Hers, Kyndryl plunges (Yahoo Finance Video)
09:25AM	Novo Nordisk Sues Hims & Hers, Seeking Ban on Copycat Drugs and Damages (The Wall Street Journal)
09:04AM	Hims & Hers scraps low-cost weight-loss pill following backlash (Proactive)
08:12AM	Hims & Hers Stock Plunges. Its Weight Loss Drug Strategy Backfired. (Barrons.com)
08:07AM	Novo Nordisk Files Lawsuit Against Hims & Hers, Seeking Ban on Copycat Drugs and Damages (The Wall Street Journal)
07:39AM	Novo Nordisk Surges as Hims & Hers Withdraws Weight-Loss Pill (GuruFocus.com)
07:36AM	Hims & Hers slumps on Wegovy backtrack and more early-moving stocks (MarketWatch)
07:28AM	Wegovy maker sues Hims & Hers after company launches $49 weight-loss pill (USA TODAY)
07:18AM	Hims & Hers Pulls Compounded Weight-Loss Pill After FDA Warning (GuruFocus.com)
06:26AM	How to Be a Better Investor? Watch Game Shows. (The Wall Street Journal)
05:11AM	Hims & Hers Stock Plunges 15%. Why Losing the Novo Wegovy Battle Is a Blow. (Barrons.com)
05:07AM	Novo Nordisk Stock Jumps After Hims & Hers Scraps Copycat Weight-Loss Pill (The Wall Street Journal)
04:40AM	Novo Nordisk Shares Jump After Hims & Hers Scraps Plan For Copycat Weight-Loss Pill (The Wall Street Journal)
04:13AM	Novo Nordisk shares rise as Hims abandons $49 weight-loss pill (Reuters)
03:53AM	Novo Nordisk jumps, Hims shares plummet after pulling $49 weight-loss pill (Investing.com)
03:30AM	Hims & Hers Super Bowl Ad For Cancer Test Raises Questions Over Reliability (Benzinga)
03:30AM	Hims & Hers stock poised for heavy losses after quick U-turn on plan for oral Wegovy competitor (MarketWatch)
Feb-08-26 10:27AM	Novo Nordisk A/S (NVO) Eyes Solidifying Its Market Position with Increased Advertising Spending (Insider Monkey)
08:39AM	Gartner, Stellantis, And Novo Nordisk Are Among Top 10 Large Cap Losers Last Week (Feb. 2-Feb. 6): Are the Others in Your Portfolio? (Benzinga)
07:57AM	Hims & Hers Halts Compounded Semaglutide Pill Offering After FDA's Crackdown Warning (Benzinga)
04:30AM	Novo Nordisk (NVO) Faces Pricing Pressure While Defending Wegovy Franchise and Advancing Oral GLP-1s (Insider Monkey)
Feb-07-26 05:35PM	Hims & Hers drops plan for knockoff of Novo Nordisk's new Wegovy weight loss pill (Associated Press Finance)
05:22PM	Hims & Hers Health Stops Offering Knockoff Wegovy Pill Amid FDA Crackdown (Investor's Business Daily)
04:22PM	Hims & Hers to Stop Offering Wegovy Copycat Drug After Regulatory Scrutiny (Barrons.com)
03:32PM	Hims & Hers abandons copycat weight-loss drug in face of FDA probe (Financial Times)
11:16AM	Hims cancels plans to sell compounded GLP-1 pill after FDA backlash (BioPharma Dive)
09:31AM	Hims & Hers Launches Compounded Version Of Wegovy, Novo Nordisk Threatens Legal Action (Benzinga)
06:07AM	Weight-loss drugs to compete on biggest stage with Super Bowl ads (Reuters)
05:30AM	The Weight-Loss Price Wars Are Breaking Big Pharmas Business Model (The Wall Street Journal)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novo Nordisk A/S	10% Owner	May 30 '25	Proposed Sale	2.14	921,897	1,972,859		May 30 08:31 AM

FAF

First American Financial Corp

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience